HDAC9 and glioblastoma: Yang et al.[91] analyzed HDAC9 expression in a large cohort of GBM patients and found high levels in 472 out of 504 glioma cases and that 33 of the 88 patient cases in the TCGA (The Cancer Genome Atlas) dataset were associated with a poor prognosis.